Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SMMT
SMMT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SMMT News
Ivonescimab Shows Promising Results in mCRC Clinical Development
9h ago
Newsfilter
VERAXA Biotech Secures $27.5 Million Financing Agreement
2d ago
Yahoo Finance
US Stocks Close Higher as Market Sentiment Improves
May 22 2026
NASDAQ.COM
US Stocks Rise, Nasdaq Hits Weekly High
May 22 2026
NASDAQ.COM
H.C. Wainwright Downgrades Summit to Neutral Amid Trial Concerns
May 22 2026
seekingalpha
US Stocks Rise as Market Optimism Grows
May 22 2026
NASDAQ.COM
GT Biopharma Doses First Patient in GTB-5550 Clinical Trial
May 18 2026
Newsfilter
GT Biopharma Launches Clinical Trial for B7-H3 Targeted Therapy
May 14 2026
Newsfilter
Investigation into Summit Therapeutics by Johnson Fistel
May 04 2026
Globenewswire
Summit Reports Q1 2026 Net Loss Exceeding Expectations
May 01 2026
stocktwits
Summit Therapeutics' Clinical Trial Update
May 01 2026
seekingalpha
Summit Therapeutics Reports Wider Q1 Loss and Clinical Progress
May 01 2026
NASDAQ.COM
Summit Therapeutics Q1 Earnings Beat Expectations
Apr 30 2026
seekingalpha
Summit Therapeutics Reports Q1 2026 Financial Results and Clinical Updates
Apr 30 2026
Newsfilter
Aehr Test Systems and MongoDB Show Active Options Trading
Apr 16 2026
NASDAQ.COM
Stifel Begins Coverage of Summit Therapeutics Inc with a Buy Rating and Sets Price Target at $45
Apr 08 2026
moomoo
Show More News
